NYC · American Strategic Investment Co. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $2.31M | - | $1.75M | $2.17M | $3.13M | - | $1.76M | $1.96M | $2.80M | - |
| Total Operating Expenses | $11.08M | - | $13.50M | $46.04M | $16.82M | - | $44.66M | $102.41M | $18.40M | - |
| D&A | $2.52M | - | $3.09M | $3.54M | $3.59M | - | $4.41M | $5.15M | $5.26M | - |
| Operating Income | ($1.48M) | - | $43.04M | ($33.81M) | ($4.51M) | - | ($29.21M) | ($86.66M) | ($2.92M) | - |
| Interest Expense | $4.05M | - | $4.12M | $5.20M | $4.70M | - | $5.28M | $5.20M | $4.70M | - |
| Income Tax | $0 | - | - | - | $0 | - | - | - | $0 | - |
| Net Income | ($7.78M) | - | $35.75M | ($41.66M) | ($8.59M) | - | ($34.48M) | ($91.85M) | ($7.61M) | - |
| EPS - Basic | ($3.04) | - | $13.60 | ($16.39) | ($3.39) | - | ($13.52) | ($36.48) | ($3.28) | - |
| EPS - Diluted | ($3.04) | - | $13.60 | ($16.39) | ($3.39) | - | ($13.52) | ($36.48) | ($3.28) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.50M | $1.30M | $3.35M | $5.31M | $7.08M | $9.78M | $5.23M | $5.22M | $5.29M | $5.29M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $445.01M | $445.16M | $448.07M | $463.99M | $499.38M | $507.07M | $567.91M | $598.92M | $689.80M | $694.17M |
| Current Liabilities | - | - | - | $99.00M | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $387.94M | $380.40M | $376.70M | $428.48M | $422.29M | $421.48M | $475.54M | $472.14M | $472.43M | $469.38M |
| Stockholders' Equity | $57.07M | $64.76M | $71.36M | $35.52M | $77.09M | $85.59M | $92.37M | $126.78M | $217.37M | $224.79M |
| Retained Earnings | ($674.84M) | ($667.06M) | ($660.37M) | ($696.12M) | ($654.46M) | ($645.87M) | ($639.22M) | ($604.74M) | ($512.89M) | ($505.28M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($182.0K) | - | - | - | ($3.04M) | - | - | - | $1.66M | - |
| Investing Cash Flow | ($101.0K) | - | - | - | ($72.0K) | - | - | - | ($364.0K) | - |
| Financing Cash Flow | $400.0K | - | - | - | $0 | - | - | - | $0 | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -1.7% | - | 8.0% | -9.0% | -1.7% | - | -6.1% | -15.3% | -1.1% | - |
| Return on equity | -13.6% | - | 50.1% | -117.3% | -11.1% | - | -37.3% | -72.4% | -3.5% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | 0.05 | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -0.4x | - | 10.4x | -6.5x | -1.0x | - | -5.5x | -16.7x | -0.6x | - |
| Equity multiplier | 7.80 | 6.87 | 6.28 | 13.06 | 6.48 | 5.92 | 6.15 | 4.72 | 3.17 | 3.09 |
| Liabilities / Assets | 0.87 | 0.85 | 0.84 | 0.92 | 0.85 | 0.83 | 0.84 | 0.79 | 0.68 | 0.68 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | 0.7x | - | - | - | - | - | - | - |
| P / B | 0.4x | - | 0.4x | 0.9x | 0.4x | - | 0.3x | 0.2x | 0.1x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | 18.5x | - | 0.5x | - | - | - | - | - | 4.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 67.3% | - | - | 61.0% | -54.6% | - | -527.0% | -1297.3% | 58.9% | - |
| Net income growth (YoY) | 9.5% | - | - | 54.6% | -12.9% | - | -267.2% | -742.7% | 35.3% | - |
| EPS growth (YoY) | 10.3% | - | - | 55.1% | -3.4% | - | -229.8% | -664.8% | 43.2% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -26.0% | -24.3% | -22.7% | -72.0% | -64.5% | -61.9% | -69.1% | -55.2% | -26.0% | -25.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Product / service
$100.0K totalTenant Reimbursement And Other Revenue$100.0K · 100.0%
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing American Strategic Investment Co. against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Apr 8, 2022 | $0.8000 |
| Jan 12, 2022 | $0.8000 |
| Oct 8, 2021 | $0.8000 |
| Jul 9, 2021 | $0.8000 |
| Apr 9, 2021 | $0.8000 |
| Jan 8, 2021 | $0.8000 |
| Oct 8, 2020 | $0.3920 |